{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:48:07Z","timestamp":1777560487064,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["No. 075-15-2022-310 from 20 April 2022"],"award-info":[{"award-number":["No. 075-15-2022-310 from 20 April 2022"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01865-9","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:44:01Z","timestamp":1739346241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Flow cytometry immune profiling of recurrent and newly diagnosed growth hormone secreting pituitary neuroendocrine tumors: comparison of two clinical cases"],"prefix":"10.1186","volume":"25","author":[{"given":"Daria","family":"Lisina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Mazeeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyona","family":"Sorokina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilya","family":"Dzhemileva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Grigoriev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilen","family":"Azizyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Shutova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Pigarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Dzeranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Melnichenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei","family":"Rumiantsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Mokrysheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Chekhonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Loguinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"issue":"4","key":"1865_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/diagnostics12040977","volume":"12","author":"L Lu","year":"2022","unstructured":"Lu L, Wan X, Xu Y, Chen J, Shu K, Lei T. Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions. Diagnostics (Basel). 2022;12(4):977. https:\/\/doi.org\/10.3390\/diagnostics12040977.","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"1865_CR2","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0021","volume":"30","author":"C Villa","year":"2023","unstructured":"Villa C, Baussart B, Assi\u00e9 G, Raverot G, Roncaroli F. The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal. Endocr Relat Cancer. 2023;30(8):e230021. https:\/\/doi.org\/10.1530\/ERC-23-0021.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"1865_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM, European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018;178(1):G1\u201324. https:\/\/doi.org\/10.1530\/EJE-17-0796.","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"1865_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.773905","volume":"17","author":"C Dai","year":"2021","unstructured":"Dai C, Liang S, Sun B, Li Y, Kang J. Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review. Front Oncol. 2021;17(11): 773905. https:\/\/doi.org\/10.3389\/fonc.2021.773905.","journal-title":"Front Oncol"},{"issue":"2","key":"1865_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11154-020-09556-7","volume":"21","author":"OM Dekkers","year":"2020","unstructured":"Dekkers OM, Karavitaki N, Pereira AM. The epidemiology of aggressive pituitary tumors (and its challenges). Rev Endocr Metab Disord. 2020;21(2):209\u201312. https:\/\/doi.org\/10.1007\/s11154-020-09556-7.","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"1865_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.608422","volume":"11","author":"C Dai","year":"2020","unstructured":"Dai C, Liang S, Sun B, Kang J. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas. Front Endocrinol (Lausanne). 2020;11(11):608422. https:\/\/doi.org\/10.3389\/fendo.2020.608422.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1865_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2020.100852","volume":"58","author":"P Marques","year":"2020","unstructured":"Marques P, Grossman AB, Korbonits M. The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol. 2020;58:100852. https:\/\/doi.org\/10.1016\/j.yfrne.2020.100852.","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"1865_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","volume":"17","author":"G Raverot","year":"2021","unstructured":"Raverot G, Ilie MD, Lasolle H, Amodru V, Trouillas J, Castinetti F, Brue T. Aggressive pituitary tumours and pituitary carcinomas. Nat Rev Endocrinol. 2021;17(11):671\u201384. https:\/\/doi.org\/10.1038\/s41574-021-00550-w.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1865_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11102-019-00976-6","volume":"22","author":"M Buchy","year":"2019","unstructured":"Buchy M, Lapras V, Rabilloud M, Vasiljevic A, Borson-Chazot F, Jouanneau E, Raverot G. Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification. Pituitary. 2019;22(5):467\u201375. https:\/\/doi.org\/10.1007\/s11102-019-00976-6.","journal-title":"Pituitary"},{"issue":"3","key":"1865_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ecl.2020.05.008","volume":"49","author":"MD Ilie","year":"2020","unstructured":"Ilie MD, Jouanneau E, Raverot G. Aggressive Pituitary Adenomas and Carcinomas. Endocrinol Metab Clin North Am. 2020;49(3):505\u201315. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.008.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"1865_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1210\/js.2019-00130","volume":"3","author":"BS Imber","year":"2019","unstructured":"Imber BS, Lin AL, Zhang Z, Keshavamurthy KN, Deipolyi AR, Beal K, Cohen MA, Tabar V, DeAngelis LM, Geer EB, Yang TJ, Young RJ. Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough? J Endocr Soc. 2019;3(9):1693\u2013706. https:\/\/doi.org\/10.1210\/js.2019-00130.","journal-title":"J Endocr Soc"},{"issue":"3","key":"1865_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1507\/endocrj.EJ23-0007","volume":"70","author":"H Nishioka","year":"2023","unstructured":"Nishioka H. Aggressive pituitary tumors (PitNETs). Endocr J. 2023;70(3):241\u20138. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0007.","journal-title":"Endocr J"},{"issue":"11","key":"1865_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3967\/bes2015.113","volume":"28","author":"CZ Li","year":"2015","unstructured":"Li CZ, Gui SB, Zong XY, Zhang YZ. The Expression of Estrogen Receptor Subtypes in Prolactinomas and Their Relationship to Tumor Biological Behavior. Biomed Environ Sci. 2015;28(11):820\u20132. https:\/\/doi.org\/10.3967\/bes2015.113.","journal-title":"Biomed Environ Sci"},{"issue":"1","key":"1865_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1210\/en.2014-1627","volume":"156","author":"X Liu","year":"2015","unstructured":"Liu X, Kano M, Araki T, Cooper O, Fukuoka H, Tone Y, Tone M, Melmed S. ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice. Endocrinology. 2015;156(1):71\u20139. https:\/\/doi.org\/10.1210\/en.2014-1627.","journal-title":"Endocrinology"},{"issue":"7","key":"1865_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","volume":"10","author":"A Di Ieva","year":"2014","unstructured":"Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K. Aggressive pituitary adenomas\u2013diagnosis and emerging treatments. Nat Rev Endocrinol. 2014;10(7):423\u201335. https:\/\/doi.org\/10.1038\/nrendo.2014.64.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"1865_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/neuonc\/noaa084","volume":"22","author":"C Shi","year":"2020","unstructured":"Shi C, Ye Z, Han J, Ye X, Lu W, Ji C, Li Z, Ma Z, Zhang Q, Zhang Y, He W, Chen Z, Cao X, Shou X, Zhou X, Wang Y, Zhang Z, Li Y, Ye H, He M, Chen H, Cheng H, Sun J, Cai J, Huang C, Ye F, Luo C, Zhou B, Ding H, Zhao Y. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma. Neuro Oncol. 2020;22(8):1114\u201325. https:\/\/doi.org\/10.1093\/neuonc\/noaa084.","journal-title":"Neuro Oncol"},{"issue":"8","key":"1865_CR17","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.3390\/ijms21082831","volume":"21","author":"S Uraki","year":"2020","unstructured":"Uraki S, Ariyasu H, Doi A, Takeshima K, Morita S, Inaba H, Furuta H, Fukuhara N, Inoshita N, Nishioka H, Nakao N, Yamada S, Akamizu T. MSH6\/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes. Int J Mol Sci. 2020;21(8):2831. https:\/\/doi.org\/10.3390\/ijms21082831.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1865_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/nop\/npv059","volume":"3","author":"Y Ji","year":"2016","unstructured":"Ji Y, Vogel RI, Lou E. Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports. Neurooncol Pract. 2016;3(3):188\u201395. https:\/\/doi.org\/10.1093\/nop\/npv059.","journal-title":"Neurooncol Pract"},{"issue":"9","key":"1865_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fendo.2018.00318","volume":"15","author":"LV Syro","year":"2018","unstructured":"Syro LV, Rotondo F, Camargo M, Ortiz LD, Serna CA, Kovacs K. Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions. Front Endocrinol (Lausanne). 2018;15(9):318. https:\/\/doi.org\/10.3389\/fendo.2018.00318.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1865_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-17-0933","volume":"178","author":"A McCormack","year":"2018","unstructured":"McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, ESE survey collaborators. Burman P;Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol. 2018;178(3):265\u201376. https:\/\/doi.org\/10.1530\/EJE-17-0933.","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"1865_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11102-018-0868-4","volume":"21","author":"G Minniti","year":"2018","unstructured":"Minniti G, Flickinger J, Tolu B, Paolini S. Management of nonfunctioning pituitary tumors: radiotherapy. Pituitary. 2018;21(2):154\u201361. https:\/\/doi.org\/10.1007\/s11102-018-0868-4.","journal-title":"Pituitary"},{"issue":"11","key":"1865_CR22","doi-asserted-by":"publisher","first-page":"R559","DOI":"10.1530\/ERC-18-0228","volume":"25","author":"D Dworakowska","year":"2018","unstructured":"Dworakowska D, Grossman AB. Aggressive and malignant pituitary tumours: state-of-the-art. Endocr Relat Cancer. 2018;25(11):R559\u201375. https:\/\/doi.org\/10.1530\/ERC-18-0228.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"1865_CR23","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2018-02461","volume":"104","author":"D Zhang","year":"2019","unstructured":"Zhang D, Way JS, Zhang X, Sergey M, Bergsneider M, Wang MB, Yong WH, Heaney AP. Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas. J Clin Endocrinol Metab. 2019;104(6):1929\u201336. https:\/\/doi.org\/10.1210\/jc.2018-02461.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1865_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/endrev\/bnac024","volume":"44","author":"MD Ilie","year":"2023","unstructured":"Ilie MD, Vasiljevic A, Bertolino P, Raverot G. Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas. Endocr Rev. 2023;44(2):297\u2013311. https:\/\/doi.org\/10.1210\/endrev\/bnac024.","journal-title":"Endocr Rev"},{"issue":"7","key":"1865_CR25","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1210\/clinem\/dgad098","volume":"108","author":"P Burman","year":"2023","unstructured":"Burman P, Casar-Borota O, Perez-Rivas LG, Dekkers OM. Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment. J Clin Endocrinol Metab. 2023;108(7):1585\u2013601. https:\/\/doi.org\/10.1210\/clinem\/dgad098. Erratum.In:JClinEndocrinolMetab.2023;108(10):e1163.doi:10.1210\/clinem\/dgad222.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1865_CR26","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1530\/EJE-20-0151","volume":"184","author":"B Sol","year":"2021","unstructured":"Sol B, de Filette JMK, Awada G, Raeymaeckers S, Aspeslagh S, Andreescu CE, Neyns B, Velkeniers B. Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment? Eur J Endocrinol. 2021;184(1):K1\u20135. https:\/\/doi.org\/10.1530\/EJE-20-0151.","journal-title":"Eur J Endocrinol"},{"issue":"Pt 23","key":"1865_CR27","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591\u20136. https:\/\/doi.org\/10.1242\/jcs.116392.","journal-title":"J Cell Sci"},{"issue":"1","key":"1865_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13045-023-01430-8","volume":"16","author":"S Liu","year":"2023","unstructured":"Liu S, Sun Q, Ren X. Novel strategies for cancer immunotherapy: counter-immunoediting therapy. J Hematol Oncol. 2023;16(1):38. https:\/\/doi.org\/10.1186\/s13045-023-01430-8.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1865_CR29","doi-asserted-by":"publisher","first-page":"e3207","DOI":"10.1210\/clinem\/dgaa449","volume":"105","author":"Z Wang","year":"2020","unstructured":"Wang Z, Guo X, Gao L, Deng K, Lian W, Bao X, Feng M, Duan L, Zhu H, Xing B. The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness. J Clin Endocrinol Metab. 2020;105(9):e3207\u201323. https:\/\/doi.org\/10.1210\/clinem\/dgaa449.","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"1865_CR30","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.3390\/cancers15215301","volume":"15","author":"DA Tapoi","year":"2023","unstructured":"Tapoi DA, Popa ML, Tanase C, Derewicz D, Gheorghi\u0219an-G\u0103l\u0103\u021beanu AA. Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy. Cancers (Basel). 2023;15(21):5301. https:\/\/doi.org\/10.3390\/cancers15215301.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1865_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11154-022-09782-1","volume":"24","author":"S Chiloiro","year":"2023","unstructured":"Chiloiro S, De Marinis L. The immune microenviroment in somatotropinomas: from biology to personalized and target therapy. Rev Endocr Metab Disord. 2023;24(2):283\u201395. https:\/\/doi.org\/10.1007\/s11154-022-09782-1. (Epub 2023 Jan 20).","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"1865_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","volume":"26","author":"JQ Lu","year":"2015","unstructured":"Lu JQ, Adam B, Jack AS, Lam A, Broad RW, Chik CL. Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas. Endocr Pathol. 2015;26(3):263\u201372. https:\/\/doi.org\/10.1007\/s12022-015-9383-6.","journal-title":"Endocr Pathol"},{"issue":"3","key":"1865_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12020-019-02145-y","volume":"67","author":"D Iacovazzo","year":"2020","unstructured":"Iacovazzo D, Chiloiro S, Carlsen E, Bianchi A, Giampietro A, Tartaglione T, Bima C, Bracaccia ME, Lugli F, Lauretti L, Anile C, Gessi M, Colosimo C, Rindi G, Pontecorvi A, Korbonits M, De Marinis L. Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours. Endocrine. 2020;67(3):651\u20138. https:\/\/doi.org\/10.1007\/s12020-019-02145-y.","journal-title":"Endocrine"},{"issue":"1","key":"1865_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11102-007-0066-2","volume":"11","author":"J Gong","year":"2008","unstructured":"Gong J, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Lopes MB, Hussaini IM, Laws ER. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary. 2008;11(1):37\u201348. https:\/\/doi.org\/10.1007\/s11102-007-0066-2.","journal-title":"Pituitary"},{"issue":"2","key":"1865_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.4287","volume":"232","author":"J Galon","year":"2014","unstructured":"Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, Nagtegaal ID, Palmqvist R, Masucci GV, Botti G, Tatangelo F, Delrio P, Maio M, Laghi L, Grizzi F, Asslaber M, D\u2019Arrigo C, Vidal-Vanaclocha F, Zavadova E, Chouchane L, Ohashi PS, Hafezi-Bakhtiari S, Wouters BG, Roehrl M, Nguyen L, Kawakami Y, Hazama S, Okuno K, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Wang Y, Kopetz S, Sinicrope FA, Scripcariu V, Ascierto PA, Marincola FM, Fox BA, Pag\u00e8s F. Towards the introduction of the \u201cImmunoscore\u201d in the classification of malignant tumours. J Pathol. 2014;232(2):199\u2013209. https:\/\/doi.org\/10.1002\/path.4287.","journal-title":"J Pathol"},{"key":"1865_CR36","doi-asserted-by":"publisher","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S. Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024;27(1):7\u201322. https:\/\/doi.org\/10.1007\/s11102-023-01360-1. Erratum in: Pituitary. 2024;27(1):88. https:\/\/doi.org\/10.1007\/s11102-023-01373-w.","DOI":"10.1007\/s11102-023-01360-1 10.1007\/s11102-023-01373-w"},{"issue":"6","key":"1865_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345\u201359. https:\/\/doi.org\/10.1038\/s41568-021-00347-z.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1865_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0090-1229(91)90063-g","volume":"60","author":"T Reichert","year":"1991","unstructured":"Reichert T, DeBruy\u00e8re M, Deneys V, T\u00f6tterman T, Lydyard P, Yuksel F, Chapel H, Jewell D, Van Hove L, Linden J, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol. 1991;60(2):190\u2013208. https:\/\/doi.org\/10.1016\/0090-1229(91)90063-g.","journal-title":"Clin Immunol Immunopathol"},{"issue":"13","key":"1865_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12979-016-0079-7","volume":"18","author":"Y Lin","year":"2016","unstructured":"Lin Y, Kim J, Metter EJ, Nguyen H, Truong T, Lustig A, Ferrucci L, Weng NP. Changes in blood lymphocyte numbers with age in vivo and their association with the levels of cytokines\/cytokine receptors. Immun Ageing. 2016;18(13):24. https:\/\/doi.org\/10.1186\/s12979-016-0079-7.","journal-title":"Immun Ageing"},{"issue":"6","key":"1865_CR40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212169","volume":"219","author":"SE Schad","year":"2022","unstructured":"Schad SE, Chow A, Mangarin L, Pan H, Zhang J, Ceglia N, Caushi JX, Malandro N, Zappasodi R, Gigoux M, Hirschhorn D, Budhu S, Amisaki M, Arniella M, Redmond D, Chaft J, Forde PM, Gainor JF, Hellmann MD, Balachandran V, Shah S, Smith KN, Pardoll D, Elemento O, Wolchok JD, Merghoub T. Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions. J Exp Med. 2022;219(6):e20212169. https:\/\/doi.org\/10.1084\/jem.20212169.","journal-title":"J Exp Med"},{"issue":"11","key":"1865_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, Lynn RC, Philip M, Rao A, Restifo NP, Schietinger A, Schumacher TN, Schwartzberg PL, Sharpe AH, Speiser DE, Wherry EJ, Youngblood BA, Zehn D. Defining \u201cT cell exhaustion.\u201d Nat Rev Immunol. 2019;19(11):665\u201374. https:\/\/doi.org\/10.1038\/s41577-019-0221-9.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1865_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2567.2005.02235.x","volume":"116","author":"EG Addison","year":"2005","unstructured":"Addison EG, North J, Bakhsh I, Marden C, Haq S, Al-Sarraj S, Malayeri R, Wickremasinghe RG, Davies JK, Lowdell MW. Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology. 2005;116(3):354\u201361. https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02235.x.","journal-title":"Immunology"},{"issue":"3","key":"1865_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/cells9030768","volume":"9","author":"R Zambello","year":"2020","unstructured":"Zambello R, Baril\u00e0 G, Manni S, Piazza F, Semenzato G. NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias. Cells. 2020;9(3):768. https:\/\/doi.org\/10.3390\/cells9030768.","journal-title":"Cells"},{"issue":"13","key":"1865_CR44","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/cells12131673.PMID:37443711;PMCID:PMC10340267","volume":"12","author":"X Chen","year":"2023","unstructured":"Chen X, Li Y, Xia H, Chen YH. Monocytes in Tumorigenesis and Tumor Immunotherapy. Cells. 2023;12(13):1673. https:\/\/doi.org\/10.3390\/cells12131673.PMID:37443711;PMCID:PMC10340267.","journal-title":"Cells"},{"issue":"7","key":"1865_CR45","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"6","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;6(7):12150. https:\/\/doi.org\/10.1038\/ncomms12150.","journal-title":"Nat Commun"},{"key":"1865_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nyas.12469","volume":"1319","author":"S Solito","year":"2014","unstructured":"Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci. 2014;1319:47\u201365. https:\/\/doi.org\/10.1111\/nyas.12469.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1865_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4274\/tjh.galenos.2022.2022.0137","volume":"39","author":"X Ren","year":"2022","unstructured":"Ren X, Tao Q, Wang H, Zhang Q, Zhou M, Liu L, Zhai Z. Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia. Turk J Haematol. 2022;39(4):230\u20136. https:\/\/doi.org\/10.4274\/tjh.galenos.2022.2022.0137.","journal-title":"Turk J Haematol"},{"key":"1865_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101346","volume":"17","author":"I Siemi\u0144ska","year":"2022","unstructured":"Siemi\u0144ska I, W\u0119glarczyk K, Walczak M, Czerwi\u0144ska A, Pach R, Rubinkiewicz M, Szczepanik A, Siedlar M, Baran J. Mo-MDSCs are pivotal players in colorectal cancer and may be associated with tumor recurrence after surgery. Transl Oncol. 2022;17:101346. https:\/\/doi.org\/10.1016\/j.tranon.2022.101346.","journal-title":"Transl Oncol"},{"key":"1865_CR49","doi-asserted-by":"publisher","first-page":"34310","DOI":"10.1038\/srep34310","volume":"6","author":"WH Yeap","year":"2016","unstructured":"Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310. https:\/\/doi.org\/10.1038\/srep34310.","journal-title":"Sci Rep"},{"issue":"3","key":"1865_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/clim.2001.5072","volume":"100","author":"J Almeida","year":"2001","unstructured":"Almeida J, Bueno C, Alguer\u00f3 MC, Sanchez ML, de Santiago M, Escribano L, D\u00edaz-Agust\u00edn B, Vaquero JM, Laso FJ, San Miguel JF, Orfao A. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)\/CD16(+)\/HLA-DR(+)\/CD14(-\/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells. Clin Immunol. 2001Sep;100(3):325\u201338. https:\/\/doi.org\/10.1006\/clim.2001.5072.","journal-title":"Clin Immunol"},{"key":"1865_CR51","doi-asserted-by":"publisher","unstructured":"Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19(6):402\u2013421. https:\/\/doi.org\/10.1038\/s41571-022-00620-6. Epub 2022 Mar 30. Erratum in: Nat Rev Clin Oncol. 2022;19(6):424. https:\/\/doi.org\/10.1038\/s41571-022-00632-2.","DOI":"10.1038\/s41571-022-00620-6 10.1038\/s41571-022-00632-2"},{"issue":"6","key":"1865_CR52","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. https:\/\/doi.org\/10.1093\/jnci\/dju124.","journal-title":"J Natl Cancer Inst."},{"key":"1865_CR53","doi-asserted-by":"publisher","unstructured":"Szyde\u0142ko J, Szyde\u0142ko\u2010Gorzkowicz M, Matyjaszek\u2010matuszek B. Neutrophil\u2010to\u2010lymphocyte, platelet\u2010to\u2010lymphocyte ratios, and systemic immune\u2010inflammation index as potential biomarkers of chronic inflammation in patients with newly diagnosed acromegaly: A single\u2010centre study. J Clin Med. 2021;10(17).https:\/\/doi.org\/10.3390\/jcm10173997.","DOI":"10.3390\/jcm10173997"},{"key":"1865_CR54","doi-asserted-by":"publisher","unstructured":"Allen BM, Hiam KJ, Burnett CE, Venida A, DeBarge R, Tenvooren I, Marquez DM, Cho NW, Carmi Y, Spitzer MH. Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Nat Med. 2020;26(7):1125\u20131134. https:\/\/doi.org\/10.1038\/s41591-020-0892-6. Epub 2020 May 25. Erratum in: Nat Med. 2024;30(5):1502. https:\/\/doi.org\/10.1038\/s41591-024-02947-2. PMID: 32451499; PMCID: PMC7384250.","DOI":"10.1038\/s41591-020-0892-6 10.1038\/s41591-024-02947-2"},{"issue":"27","key":"1865_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.598887","volume":"25","author":"X Huang","year":"2021","unstructured":"Huang X, Xu J, Wu Y, Sheng L, Li Y, Zha B, Sun T, Yang J, Zang S, Liu J. Alterations in CD8+ Tregs, CD56+ Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs). Pathol Oncol Res. 2021Mar;25(27): 598887. https:\/\/doi.org\/10.3389\/pore.2021.598887.","journal-title":"Pathol Oncol Res"},{"issue":"9","key":"1865_CR56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1479-5876-9-146","volume":"29","author":"ML Ascierto","year":"2011","unstructured":"Ascierto ML, De Giorgi V, Liu Q, Bedognetti D, Spivey TL, Murtas D, Uccellini L, Ayotte BD, Stroncek DF, Chouchane L, Manjili MH, Wang E, Marincola FM. An immunologic portrait of cancer. J Transl Med. 2011Aug;29(9):146. https:\/\/doi.org\/10.1186\/1479-5876-9-146.","journal-title":"J Transl Med"},{"issue":"10","key":"1865_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.908389","volume":"30","author":"V Melo","year":"2022","unstructured":"Melo V, Bremer E, Martin JD. Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment. Front Cell Dev Biol. 2022May;30(10): 908389. https:\/\/doi.org\/10.3389\/fcell.2022.908389.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1865_CR58","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012Mar 15;12(4):298\u2013306. https:\/\/doi.org\/10.1038\/nrc3245.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1865_CR59","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/jcm8050695","volume":"8","author":"M Sato","year":"2019","unstructured":"Sato M, Tamura R, Tamura H, Mase T, Kosugi K, Morimoto Y, Yoshida K, Toda M. Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors. J Clin Med. 2019May 16;8(5):695. https:\/\/doi.org\/10.3390\/jcm8050695.","journal-title":"J Clin Med"},{"issue":"5","key":"1865_CR60","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.molcel.2020.02.013","volume":"77","author":"X He","year":"2020","unstructured":"He X, Xu C. PD-1: A Driver or Passenger of T Cell Exhaustion? Mol Cell. 2020Mar 5;77(5):930\u20131. https:\/\/doi.org\/10.1016\/j.molcel.2020.02.013.","journal-title":"Mol Cell"},{"issue":"3","key":"1865_CR61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12022-021-09673-2","volume":"32","author":"J Turchini","year":"2021","unstructured":"Turchini J, Sioson L, Clarkson A, Sheen A, Gill AJ. PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours. Endocr Pathol. 2021Sep;32(3):408\u201314. https:\/\/doi.org\/10.1007\/s12022-021-09673-2.","journal-title":"Endocr Pathol"},{"issue":"1","key":"1865_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-018-2844-2","volume":"139","author":"PF Wang","year":"2018","unstructured":"Wang PF, Wang TJ, Yang YK, Yao K, Li Z, Li YM, Yan CX. The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy. J Neurooncol. 2018Aug;139(1):89\u201395. https:\/\/doi.org\/10.1007\/s11060-018-2844-2.","journal-title":"J Neurooncol"},{"issue":"12","key":"1865_CR63","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.2147\/OTT.S221340","volume":"15","author":"J Cai","year":"2019","unstructured":"Cai J, Wang D, Zhang G, Guo X. The Role Of PD-1\/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy. Onco Targets Ther. 2019Oct;15(12):8437\u201345. https:\/\/doi.org\/10.2147\/OTT.S221340.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"1865_CR64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxw025","volume":"28","author":"Y Takeuchi","year":"2016","unstructured":"Takeuchi Y, Nishikawa H. Roles of regulatory T cells in cancer immunity. Int Immunol. 2016Aug;28(8):401\u20139. https:\/\/doi.org\/10.1093\/intimm\/dxw025.","journal-title":"Int Immunol"},{"issue":"13","key":"1865_CR65","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco LM, Salinas VH, Brown KE, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. 2009;206(13):3015\u201329. https:\/\/doi.org\/10.1084\/jem.20090847.","journal-title":"J Exp Med"},{"issue":"2","key":"1865_CR66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.immuni.2018.05.006","volume":"49","author":"C Stathopoulou","year":"2018","unstructured":"Stathopoulou C, Gangaplara A, Mallett G, et al. PD-1 inhibitory receptor downregulates asparaginyl endopeptidase and maintains FoxP3 transcription factor stability in induced regulatory T cells. Immunity. 2018;49(2):247\u2013263 e247. https:\/\/doi.org\/10.1016\/j.immuni.2018.05.006.","journal-title":"Immunity."},{"issue":"1","key":"1865_CR67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-023-00460-1","volume":"11","author":"E Zhang","year":"2023","unstructured":"Zhang E, Ding C, Li S, Zhou X, Aikemu B, Fan X, Sun J, Zheng M, Yang X. Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy. Biomark Res. 2023;11(1):28. https:\/\/doi.org\/10.1186\/s40364-023-00460-1.","journal-title":"Biomark Res"},{"issue":"1","key":"1865_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","volume":"19","author":"SY Wu","year":"2020","unstructured":"Wu SY, Fu T, Jiang YZ, Shao ZM. Natural killer cells in cancer biology and therapy. Mol Cancer. 2020;19(1):120. https:\/\/doi.org\/10.1186\/s12943-020-01238-x.","journal-title":"Mol Cancer"},{"issue":"12","key":"1865_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189615","volume":"12","author":"V Perri","year":"2017","unstructured":"Perri V, Gianchecchi E, Cifaldi L, Pellegrino M, Giorda E, Andreani M, Cappa M, Fierabracci A. Identification of GAD65 AA 114\u2013122 reactive \u201cmemory-like\u201d NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers. PLoS ONE. 2017;12(12):e0189615. https:\/\/doi.org\/10.1371\/journal.pone.0189615.","journal-title":"PLoS ONE"},{"issue":"6","key":"1865_CR70","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1317411","volume":"6","author":"M Pal","year":"2017","unstructured":"Pal M, Schwab L, Yermakova A, Mace EM, Claus R, Krahl AC, Woiterski J, Hartwig UF, Orange JS, Handgretinger R, Andr\u00e9 MC. Tumor-priming converts NK cells to memory-like NK cells. Oncoimmunology. 2017Apr 18;6(6): e1317411. https:\/\/doi.org\/10.1080\/2162402X.2017.1317411.","journal-title":"Oncoimmunology"},{"issue":"5","key":"1865_CR71","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00262-020-02750-1","volume":"70","author":"MP Zaborowski","year":"2021","unstructured":"Zaborowski MP, Stefens-Stawna P, Osztynowicz K, Piorunek T, Batura-Gabryel H, Dyzmann-Sroka A, Kozubski W, Nowak-Markwitz E, Michalak S. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy. Cancer Immunol Immunother. 2021;70(5):1277\u201389. https:\/\/doi.org\/10.1007\/s00262-020-02750-1.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1865_CR72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-023-01473-x","volume":"16","author":"X Cheng","year":"2023","unstructured":"Cheng X, Wang H, Wang Z, Zhu B, Long H. Tumor-associated myeloid cells in cancer immunotherapy. J Hematol Oncol. 2023;16(1):71. https:\/\/doi.org\/10.1186\/s13045-023-01473-x.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1865_CR73","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/eji.1830230902","volume":"23","author":"HW Ziegler-Heitbrock","year":"1993","unstructured":"Ziegler-Heitbrock HW, Fingerle G, Str\u00f6bel M, Schraut W, Stelter F, Sch\u00fctt C, Passlick B, Pforte A. The novel subset of CD14+\/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol. 1993;23(9):2053\u20138. https:\/\/doi.org\/10.1002\/eji.1830230902.","journal-title":"Eur J Immunol"},{"key":"1865_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.848367","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Wang M, Guo H, Hou J, Zhang Y, Li M, Wu X, Chen X, Wang L. Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma. Front Immunol. 2022;13: 848367. https:\/\/doi.org\/10.3389\/fimmu.2022.848367.","journal-title":"Front Immunol"},{"key":"1865_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816460","volume":"2015","author":"T R\u0151szer","year":"2015","unstructured":"R\u0151szer T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm. 2015;2015: 816460. https:\/\/doi.org\/10.1155\/2015\/816460.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1865_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/path.2370","volume":"216","author":"Y Komohara","year":"2008","unstructured":"Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol. 2008;216(1):15\u201324. https:\/\/doi.org\/10.1002\/path.2370.","journal-title":"J Pathol"},{"key":"1865_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","volume":"518","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Huang L, Qin G, Qiao Y, Ren F, Shen C, Wang S, Liu S, Lian J, Wang D, Yu W, Zhang Y. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Cancer Lett. 2021;518:35\u201348. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.009.","journal-title":"Cancer Lett"},{"issue":"2","key":"1865_CR78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19(2):108\u201319. https:\/\/doi.org\/10.1038\/s41590-017-0022-x.","journal-title":"Nat Immunol"},{"issue":"2","key":"1865_CR79","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/healthcare10020342","volume":"10","author":"A Caruntu","year":"2022","unstructured":"Caruntu A, Moraru L, Surcel M, Munteanu A, Costache DO, Tanase C, Constantin C, Scheau C, Neagu M, Caruntu C. Persistent Changes of Peripheral Blood Lymphocyte Subsets in Patients with Oral Squamous Cell Carcinoma. Healthcare (Basel). 2022;10(2):342. https:\/\/doi.org\/10.3390\/healthcare10020342.","journal-title":"Healthcare (Basel)"},{"issue":"12","key":"1865_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.785050","volume":"2","author":"C Han","year":"2021","unstructured":"Han C, Lin S, Lu X, Xue L, Wu ZB. Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches. Front Endocrinol (Lausanne). 2021;2(12): 785050. https:\/\/doi.org\/10.3389\/fendo.2021.785050.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01865-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01865-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01865-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:50:40Z","timestamp":1739461840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01865-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1865"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01865-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Local Ethics Committee of the Endocrinology Research Centre (Approval No. 17, dated 27 September 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the patients\u2019 details and\/or clinical images was obtained from the patients. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}